tert-Butyl (5-ethynyl-1-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-yl)carbamate

Catalog No. :
ACZMOO800
CAS No. :
2916870-78-3
Molecular Formula :
C23H27BFNO4
Molecular Weight :
411.28

IUPAC Name:tert-butyl (5-ethynyl-1-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-yl)carbamate

tert-Butyl (5-ethynyl-1-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (5-ethynyl-1-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-yl)carbamate
IUPAC Nametert-butyl (5-ethynyl-1-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-yl)carbamate
Molecular FormulaC23H27BFNO4
Molecular Weight411.28
SMILESO=C(NC1=C(F)C2=C(C(C#C)=CC=C2)C(B3OC(C)(C(C)(C)O3)C)=C1)OC(C)(C)C
InChI KeyAZIIYQWQHYLSIZ-UHFFFAOYSA-N
Synonymtert-Butyl (5-ethynyl-1-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-2-yl)carbamate
CAS No.2916870-78-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACZMOO800 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACZMOO800 route product structure diagram
    ACZMOO8002916870-78-3
Inquiry

2. ACZMOO800 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZMOO800 route product structure diagram
    ACZMOO8002916870-78-3
Inquiry

Comments (0)